AnchorMesh
Resilient Anchoring Implants for Arthroscopic Orthopedic Fixation
Company Overview
Snapshot
Founded in June 2021 by Tamir Ben David, AnchorMesh operates with 1–10 employees. The company has secured funding across one round from Israel Innovation Authority. In December 2024, AnchorMesh received a grant from the Israel Innovation Authority, signaling early validation for its orthopedic fixation technology.
Business overview
AnchorMesh develops a single, cost-effective fixation technology anchor platform designed for a wide range of orthopedic procedures, specifically targeting soft cancellous bone. Its core product focuses on maximizing fixation contact area within bone while preserving bone integrity and supporting arthroscopic workflows. The company operates within the Health Tech & Life Sciences sector, serving the healthcare industry, including providers and patients, with medical devices and assistive devices.
Log in to access full profile ›Company Intelligence Q&A
- When was AnchorMesh founded?
- AnchorMesh was founded in June 2021.
- Who are the founders of AnchorMesh?
- AnchorMesh was co-founded by Tamir Ben David.
- What is AnchorMesh's primary focus?
- AnchorMesh focuses on developing resilient anchoring implants for arthroscopic orthopedic fixation, aiming to provide a cost-effective solution for various orthopedic procedures in soft cancellous bone.
- What is the employee count for AnchorMesh?
- AnchorMesh currently has 1–10 employees.
- Has AnchorMesh received any grants or funding?
- In December 2024, AnchorMesh secured a grant from the Israel Innovation Authority.